February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies, has announced the launch of EMBOGUARD, a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.
Ischemic strokes, caused by the formation of a local blood clot or an embolus that travels to a vessel in the brain and obstructs blood supply, account for 85%1 of all strokes worldwide. Mechanical thrombectomy (MT), a minimally invasive procedure to remove a clot, is the recommended treatment option for acute ischemic stroke.2 The EMBOGUARD Balloon Guide Catheter is designed to optimize removal of clots by controlling blood flow locally during MT procedures.3 Balloon guide catheters increase first pass recanalization, reduce procedure time and reduce the odds of clot fragments breaking off and causing distal emboli.4 Distal emboli in an endovascular procedure can result in new ischemic events.
“Without timely and effective treatment of stroke, patients can suffer from lifelong disability or dependency,” said David Fiorella MD, PhD, Director of Cerebrovascular Center, Stony Brook University Hospital. “The benefits of balloon guide catheters are becoming increasingly recognized for their ability to maximize patient outcomes. By adding this innovation to their Stroke Solutions portfolio, CERENOVUS will be arming physicians with the tools they need to better serve our patients, potentially increasing the chances to live a functional and fulfilling life post-stroke.”
EMBOGUARD is the latest addition to join CERENOVUS Stroke Solutions - a suite of technologies designed with compatibility in mind to assist physicians in performing mechanical thrombectomy procedures. Launched in 2020, CERENOVUS Stroke Solutions now includes the EMBOTRAP III Revascularization Device, the PROWLER™ EX Microcatheter, the CERENOVUS™ Large Bore Catheter as well as both the EMBOGUARD Balloon Guide Catheter and the CEREBASE Guide Sheath.
“We’re proud to announce the addition of EMBOGUARD into our family of CERENOVUS Stroke Solutions,” said Mark Dickinson, Worldwide President, CERENOVUS. “The addition of this device to our portfolio of technologies provides physicians with an innovative and comprehensive set of tools to treat their patients, building on our commitment to changing the trajectory of stroke.”
Reference:
- Ischaemic stroke. Stroke Association. Stroke.org.uk. www.stroke.org.uk.
- Parthasarathy R and Gupta V. Ann Indian Acad Neurol. 2020 Jan-Feb 23(1): 13–19. www.ncbi.nlm.nih.gov. Last accessed online September 2020.
- EMBOGUARD Simulated Clot Retrieval Report. 500756583 | Rev: A.6. Released: 15-Jul-2021. State: Released. CN: 231147
- Brinjikji, Waleed, et al. Impact of balloon guide catheter on technical and clinical outcomes: a systematic review and metaanalysis. J NeuroIntervent Surg. 2017. jnis.bmj.com.
June 13, 2024 
